AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GLUCOSAMINE
5 registrations across 3 African markets— 4 active
Markets with GLUCOSAMINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Osteoflex Night Caplet Caplet | 🇳🇬Nigeria | United African Laboratories Ltd | active | May 2029 |
| Flexsa Glucosamine Sulfate 1500 mg Powder Powder | 🇳🇬Nigeria | Mega Lifesciences Nigeria Limited | active | Aug 2025 |
| STRUCTOFLEX Gélule / 625 mg | 🇹🇳Tunisia | PIERRE FABRE MEDICAMENT . | expired | Jan 2018 |
| CARTISPUR Tablet | 🇰🇪Kenya | AQUATIC IMPEX FZC | active | — |
| FOUR JOINT OMEGA CAPSULES Capsule, Soft | 🇰🇪Kenya | FOURMEDS PHARMACEUTICALS LTD | active | — |
GLUCOSAMINE in Africa — Regulatory Overview
GLUCOSAMINE is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Nigeria, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 4 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.